Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 8Polycystic Ovary Syndrome 7Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 6Colorectal Neoplasms 5Lung Neoplasms 4Metabolic Syndrome 3Insulin Resistance 3Adenocarcinoma of Lung 3Lymphoma, Large B-Cell, Diffuse 2Glioblastoma 2Carcinoma, Renal Cell 2pCR Rate 1Weight Gain 1Thyroid Diseases 1Thoracic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Motor Activity 1Melanoma 1Lymphoma 1Leukoplakia 1Leukemia, Myelomonocytic, Acute 1

Interventions

Doxorubicin 5Cyclophosphamide 3Trastuzumab 2Docetaxel 2Dexrazoxane 2empagliflozin 1Taxes 1Tamoxifen 1Razoxane 1Radiotherapy 1Radiation 1Paclitaxel 1Neoadjuvant Therapy 1Methotrexate 1Metformin 1Leucovorin 1High-Intensity Interval Training 1Hematologic Tests 1Filgrastim 1Exercise 1Epirubicin 1Echocardiography 1Cisplatin 1Chemotherapy, Adjuvant 1Carvedilol 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Cardiotoxicity × Metformin × Clear all
NCT02472353 2019-10-16

Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer

Avera McKennan Hospital & University Health Center

Phase 2 Terminated
30 enrolled 10 charts
Breast

Breast Neoplasms, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡